We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cell-line Derived Controls for Diagnostic Assay Development
Product News

Cell-line Derived Controls for Diagnostic Assay Development

Cell-line Derived Controls for Diagnostic Assay Development
Product News

Cell-line Derived Controls for Diagnostic Assay Development

Image Credit: AMSBIO

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Cell-line Derived Controls for Diagnostic Assay Development"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO announce the addition of mutation cell line Formalin-Fixed Paraffin-Embedded (FFPE) samples and isolated genomic DNA (gDNA) controls to its extensive range of cell line reference standards.

In both routine clinical use and diagnostic assay development, biologically-relevant positive and negative controls represent an invaluable resource. To ensure accuracy and reproducibility during IVD assay development and established diagnostic tests, reference standards for genomic DNA analysis and Immunohistochemistry (IHC) assays are an essential tool. However reliable sources of reference material for rarer genetic profiles remain a constant challenge.


IsoMax reference standardshave been accurately engineered to model the genetics of specific patient populations in vitro. These unique new reference standards can be directly incorporated into sample processing workflows for assay optimization, evaluation of sensitivity and specificity as well as monitoring the impact of workflow changes on downstream analysis.


Building on the CellMax range of more than 50 well-known cancer cell line FFPE controls, IsoMax reference standards provide a renewable source of control material for recognized mutations in cancer markers.  Based on CRISPR/Cas9 isogenic cell lines, a wide range of mutations are offered from target genes, including EGFR, KRAS, BRAF, and PIK3CA.


Available in multiple formats, including FFPE blocks, slides, scrolls, and isolate gDNA, IsoMax and CellMax standards provide an inexhaustible supply of consistent positive and negative controls.


Advertisement